TY - JOUR
T1 - Evidence based outcomes of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry
AU - Mitchell, Sunny D.
AU - Willey, Shawna C.
AU - Beitsch, Peter
AU - Feldman, Sheldon
N1 - Funding Information:
Kelemen, Andrew Kenler, Patricia Kennedy, Jessica Keto, Alison Laidley, Camelia Lawrence, Laura Lazarus, Christine Lee, Pamela Li, Roberta Lilly, Suzanne Lynn, Robert Maganini, Donna-Marie Manasseh, Wendy Mikkelson, Alison Mishkit, Sunny Mitchell, Brenda Moorthy, Christine Moulds-Merritt, Mary Murray, Leigh Neumayer, Bridget Oppong, William Owens, Melody Paulishak, Catherine Plzak, Winnie Polen, Laura Pomerenke, Catherine Porter, Mary Pronovost, Stephen Ray, Adam Riker, David Rock, Margaret Sacco, Michael Schultz, Ingrid Sharon, Jeannie Shen, Paulomi Shroff, Diane Stoller, Walton Taylor, Kennith Thompson, Shannon Tierney, Judy Tjoe, Lisa Torp, Eleni Tousimis, John Turner, Gary Unzeitig, Aislinn Vaughan, Anna Voltura, Irene Wapnir, Barbara Ward, Barbara Wexelman, Eric Whitacre, Thomas Whitacre, Lisa Wiechmann, Shawna Willey, Brynn Wolff; (II) American Society of Breast Surgeons: Mena Jalai, Sharon Grutman, Margaret Schlosnagle, Marti Boyer, Ben Schlosnagle, and Jane Schuster; (III) Data analysis & interpretation: Biostat Inc. Maureen Lyden. The ASBrS NSMR receives unrestricted educational grants from Invuity, Medtronic, and LifeCell.
Publisher Copyright:
© Gland Surgery.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Background: The American Society of Breast Surgeons (ASBrS) Nipple Sparing Mastectomy Registry (NSMR) is a prospective, non-randomized, IRB approved, multi-institutional registry. The purpose of this Registry is to provide a large, prospective, non-randomized database of patient characteristics, tumor characteristics, surgical technique, and outcome (both aesthetic and oncologic) of the nipple sparing mastectomy (NSM). Methods: Data is entered into the ASBrS NSMR, housed within the Mastery of Surgery Program, after patients consent to participation. Each investigator routinely offers NSM in their practice has obtained IRB approval and completed forms of agreement to participate in the ASBrS NSMR. Results: This data set represents a total of 1,935 NSMs performed on 1,170 patients by 98 investigators from 70 institutions/sites. Of the 1,935 NSMs: 833 were performed for an indication of cancer [594 invasive carcinoma and 239 for ductal carcinoma in situ (DCIS)] and 1,102 were prophylactic. Of the 1,170 total patients, 352 underwent a unilateral and 818 underwent a bilateral NSM. Recurrence at a mean follow-up of 31 months/median follow-up of 27 months, with a range of 9.7 to 58.3 months since surgery was 1.4% with no recurrences at the nipple or nipple areola complex (NAC). Cancer occurrence (0.3%) also did not involve the nipple/NAC. Overall patient satisfaction of excellent/good: 94.9% and overall cosmesis (surgeon rated) of excellent/good was 96.4%. Overall infection rates included flap infection of 4.4%, NAC complication rate of 4.5% (defined as necrosis/other or ischemia/epidermolysis requiring surgery), and a 10% rate of NAC epidermolysis with full recovery. Conclusions: NSMs were performed on breasts with a variety of sizes and degrees of ptosis, via multiple incisions, dissection and reconstruction techniques with low complication rates and high patient satisfaction and surgeon rated cosmesis.
AB - Background: The American Society of Breast Surgeons (ASBrS) Nipple Sparing Mastectomy Registry (NSMR) is a prospective, non-randomized, IRB approved, multi-institutional registry. The purpose of this Registry is to provide a large, prospective, non-randomized database of patient characteristics, tumor characteristics, surgical technique, and outcome (both aesthetic and oncologic) of the nipple sparing mastectomy (NSM). Methods: Data is entered into the ASBrS NSMR, housed within the Mastery of Surgery Program, after patients consent to participation. Each investigator routinely offers NSM in their practice has obtained IRB approval and completed forms of agreement to participate in the ASBrS NSMR. Results: This data set represents a total of 1,935 NSMs performed on 1,170 patients by 98 investigators from 70 institutions/sites. Of the 1,935 NSMs: 833 were performed for an indication of cancer [594 invasive carcinoma and 239 for ductal carcinoma in situ (DCIS)] and 1,102 were prophylactic. Of the 1,170 total patients, 352 underwent a unilateral and 818 underwent a bilateral NSM. Recurrence at a mean follow-up of 31 months/median follow-up of 27 months, with a range of 9.7 to 58.3 months since surgery was 1.4% with no recurrences at the nipple or nipple areola complex (NAC). Cancer occurrence (0.3%) also did not involve the nipple/NAC. Overall patient satisfaction of excellent/good: 94.9% and overall cosmesis (surgeon rated) of excellent/good was 96.4%. Overall infection rates included flap infection of 4.4%, NAC complication rate of 4.5% (defined as necrosis/other or ischemia/epidermolysis requiring surgery), and a 10% rate of NAC epidermolysis with full recovery. Conclusions: NSMs were performed on breasts with a variety of sizes and degrees of ptosis, via multiple incisions, dissection and reconstruction techniques with low complication rates and high patient satisfaction and surgeon rated cosmesis.
KW - Nipple sparing mastectomy (NSM)
KW - Outcome data
UR - http://www.scopus.com/inward/record.url?scp=85048042227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048042227&partnerID=8YFLogxK
U2 - 10.21037/gs.2017.09.10
DO - 10.21037/gs.2017.09.10
M3 - Article
AN - SCOPUS:85048042227
SN - 2227-684X
VL - 7
SP - 247
EP - 257
JO - Gland Surgery
JF - Gland Surgery
IS - 3
ER -